Inter- and intra-assay reproducibility of microplate alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 46, Issue 10, 2008, Pages 3526-3529

  Leonard, Brian ^a   Coronel, Jorge ^a   Siedner, Mark ^a   Grandjean, Louis ^a   Caviedes, Luz ^a   Navarro, Pilar ^a   Gilman, Robert H ^a,b,c,d   Moore, David A J ^a,b,c,d  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPUTUM CULTURE;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; REPRODUCIBILITY OF RESULTS; XANTHENES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 53649083154     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02083-07     Document Type: Article

References (13)

1. Aziz, M. A., A. Wright, A. Laszlo, A. De Muynck, F. Portaels, A. Van Deun, C. Wells, P. Nunn, L. Blanc, and M. Raviglione. 2006. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368:2142-2154.
2. Chauca, J. A., J. C. Palomino, and H. Guerra. 2007. Evaluation of the accuracy of the microplate Alamar Blue assay for rapid detection of MDR-TB in Peru. Int. J. Tuberc. Lung Dis. 11:820-822.
3. Collins, L., and S. G. Franzblau. 1997. Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1004-1009.
4. Franzblau, S. G., R. S. Witzig, J. C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M. T. Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson, and R. H. Gilman. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.
5. Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575-1580.
6. Kumar, M., I. A. Khan, V. Verma, and G. N. Qazi. 2005. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 9:939-941.
7. Landis, J. R., and G. G. Koch. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
8. Luna-Herrera, J., G. Martinez-Cabrera, R. Parra-Maldonado, J. A. Enciso-Moreno, J. Torres-Lopez, F. Quesada-Pascual, R. Delgadillo-Polanco, and S. G. Franzblau. 2003. Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 22:21-27.
9. Madison, B., B. Robinson-Dunn, I. George, W. Gross, H. Lipman, B. Metchock, A. Sloutsky, G. Washabaugh, G. Mazurek, and J. Ridderhof. 2002. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J. Clin. Microbiol. 40:3976-3979.
10. Martin, A., F. Portaels, and J. C. Palomino. 2007. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 59:175-183.
11. Moore, D. A., C. A. Evans, R. H. Gilman, L. Caviedes, J. Coronel, A. Vivar, E. Sanchez, Y. Pinedo, J. C. Saravia, C. Salazar, R. Oberhelman, M. G. Hollm-Delgado, D. LaChira, A. R. Escombe, and J. S. Friedland. 2006. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N. Engl. J. Med. 355:1539-1550.
12. Reis, R. S., I. Neves, Jr., S. L. Lourenco, L. S. Fonseca, and M. C. Lourenco. 2004. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J. Clin. Microbiol. 42:2247-2248.
13. Sungkanuparph, S., R. Pracharktam, A. Thakkinstian, B. Buabut, and W. Kiatatchasai. 2002. Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes. J. Med. Assoc. Thai. 85:820-824.